Further validation of poor prognosis for pediatric KMT2A-rearranged leukemia and the need for rapid integration of targeted therapies for these patients

Transl Pediatr. 2024 Feb 29;13(2):370-375. doi: 10.21037/tp-23-567. Epub 2024 Feb 27.

Authors

Joshua W Goldman¹, Rajen J Mody¹

Affiliation

¹ Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA.

No abstract available

Keywords: Acute lymphoblastic leukemia (ALL); KMT2A; menin; mixed lineage leukemia (MLL).

Publication types

Editorial
Comment